Patent details

91067 Product Name: Trastuzumab et ses variantes et dérivés immuno chimiques, y compris les immotoxines.

Basic Information

Publication number:
91067
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP929142206
Legal Status:
Expired
Application number:
91067
First applicant's nationality:
Procedural language:
French

Marketing Authorization

1

Marketing Authorization Number:
IKS-No 55065 01 - Herceptin-trastuzumab
Marketing Authorization Type:
Marketing Authorization Date:
29/07/1999
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Switzerland (CH)

2

Marketing Authorization Number:
EU/1/00/145/001 - Herceptin- trastuzumab
Marketing Authorization Type:
Marketing Authorization Date:
28/08/2000
Marketing Authorization Status:
Accepted
Marketing Authorization Country:

Dates

Filing date:
02/04/2004
First Marketing Authorization date:
29/07/1999
Grant date:
02/06/2004
Activation date:
15/06/2012
Publication date:
02/06/2004
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
29/07/2014
SPC Extension Expiration:
29/07/2014
Rejection date:
Withdrawal date:

Owner

From:
02/04/2004
 
 

Name:
Genentech Inc.
Address:
1 DNA Way, South San Francisco, CA 94080-4990, United States (US)

Agent

Name:
WAXWEILER Jean
From:
02/04/2004
Address:
PO Box 1502, 1015, Luxembourg, Luxembourg (LU)
To:

Inventor

1

Name:
PRESTA Leonard, G.
Address:
United States (US)

2

Name:
CARTER Paul, J.
Address:
United States (US)
Filing date Document type Number of pages